Arletta Pharma Solutions

Arletta Pharma Solutions is a women’s health company focused on developing pharmaceutical solutions for sexual dysfunction, particularly Hypoactive Sexual Desire Disorder (HSDD) and Female Sexual Interest/Arousal Disorder (FSIAD). Its mission is to help women affected by these conditions feel like themselves again, recognizing that reduced desire and arousal can affect wellbeing, self-esteem, and relationships.

The company’s approach is informed by research into the neurobiological mechanisms involved in sexual excitation and inhibition. Its flagship product, Lybrido, is designed for women with FSIAD or HSDD who are relatively insensitive to sexual cues and experience difficulty with arousal. Arletta says Lybrido was developed through 15 years of research, and that clinical studies have shown statistically and clinically relevant improvements in women’s sexual experiences with its use.

Arletta also provides information about HSDD and FSIAD, the science behind its product, and developments in women’s sexual health. Based in Amsterdam, the company participates in the wider field through media updates and engagement with scientific and professional events.